Table: Sapporo Clinical Lab - 9-MTH group results

Sapporo Clinical Laboratory

09/02/2024 06:30

Feb 9 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2023        Dec 31, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             14.85               15.25            19.56    
                 (-2.6 pct)          (+6.8 pct)       (-2.8 pct)  
  Operating        414 mln             816 mln          541 mln   
                 (-49.2 pct)         (-24.8 pct)      (-46.3 pct) 
  Recurring        417 mln             971 mln          486 mln   
                 (-57.0 pct)         (-14.7 pct)      (-58.0 pct) 
  Net              311 mln             493 mln          307 mln   
                 (-36.7 pct)         (-25.5 pct)      (-45.9 pct) 
  EPS             93.67 yen          147.85 yen        92.28 yen  
  Ann Div                             23.00 yen        23.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             23.00 yen        23.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T